×

Show moreShow less

Show moreShow less

Evidence-Based Practices Resource Center

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders. The Evidence-Based Practices Resource Center provides communities, clinicians, policy-makers and others with the information and tools to incorporate evidence-based practices into their communities or clinical settings.

Published on 01/24/2025

SAMHSA National Guidance for Substance Use Disorder Care

SAMHSA’s new National Guidance on Essential Specialty Substance Use Disorder (SUD) Care articulates a core or essential set of services for adults with SUD that should be available at any specialty SUD treatment facility in the United States.

Published on 01/24/2025

SAMHSA National Behavioral Health Crisis Care Guide

The National Behavioral Health Crisis Care Guidance provides a framework for transforming behavioral health crisis care systems in communities throughout the United States with the goal of saving lives by helping anyone experiencing a behavioral health crisis anytime, anywhere. It also includes a draft of a detailed implementation guide for Mobile Crisis Team services in […]

Published on 01/24/2025

Integrating Behavioral Health Services Within Specialty Practices Serving Adults...

SAMHSA has issued two new papers on integration of behavioral health care in specialty care settings such as oncology and gastroenterology clinics. One paper focuses on care for adults and the other pediatric populations. The two papers discuss examples of integrated care models, key components of integrated care models and examples. The goal of these […]

Published on 01/24/2025

DEA and HHS Issue Final Telemdicine Rule for Buprenorphine Access

The Drug Enforcement Administration (DEA), together with the Department of Health and Human Services (HHS), finalized telemedicine flexibility regulations for the prescribing of medications for opioid use disorder, including buprenorphine. This final rule makes permanent the buprenorphine-related telemedicine flexibilities that DEA and HHS had extended through the end of 2025.

Published on 01/17/2025

Preventing Substance Use Among Young Adults with Disabilities

This advisory highlights the need for primary substance use prevention programs for young adults ages 18 to 25 with disabilities, provides guidance to prevention specialists on designing and tailoring these programs, and describes factors that may affect the delivery of prevention.

Published on 01/14/2025